Introduction: Intrathoracic negative pressure therapy is an adjunct to standard methods of complex empyema management in debilitated patients. Nevertheless, the use of endoscopic one-way endobronchial valves to successfully close large bronchopleural fistulas in patients with advanced pleural empyema has been described in only a few case reports. Aim: To present our experience in managing complex pleural empyema using thoracostomy with intrathoracic negative pressure therapy and/or endobronchial valve implantation. Material and methods: We retrospectively analyzed data from 13 consecutive patients (11 men, mean age: 56 years, range: 38-80 years) who were treated for pleural empyema using thoracostomy with intrathoracic negative pressure therapy and/or endobronchial valve implantation between October 2015 and November 2017. Results: The control of empyema was satisfactory in 12 patients; however, one patient died from sepsis-related multiorgan failure despite complete cessation of air leak on day 9 after endobronchial valve implantation. The overall success rate for the final closure of the chest wall was 9/12 patients (75%): in 5 patients, the wall closed spontaneously, and in 4, the wall was closed using thoracomyoplasty. Conclusions: Thoracostomy with intrathoracic negative pressure therapy, endobronchial valve implantation with tube drainage, and a combination of the two could adequately manage patients with pleural empyema with or without a persistent air leakage fistula.
Introduction: The identification of sliding hiatal hernia (SHH) less than 3 cm in size using barium swallow fluoroscopy (BSF) and oesophagogastroduodenoscopy (OGD) was recently noted as a non-reliable method, allowing for approximately 2 cm of inherent error in its size estimate. Aim of the research: We aimed to develop a reliable method, which could be used for preoperative visualisation and accurate anatomic depiction of any hiatal hernia and anatomical abnormalities in patients with incomplete gastro-oesophageal reflux disease (GORD) symptom remission after appropriate medical therapy. Material and methods: Within the period 2015-2017, 29 GORD patients (15 women, mean age 51 years) with incomplete symptom resolution on acid inhibition and equivocal findings as for SHH after endoscopy and/or BSF, were evaluated before laparoscopic anti-reflux surgery (LARS) using a computed tomography scan with a Sengstaken-Blakemore tube (CTSBT) provocation probe to confirm hernia existence. We calculated the sensitivity of each of these diagnostic tests. Results: SHH was diagnosed in 21 patients by OGD and/or BSF, but during the surgery this diagnosis was confirmed in 18 patients. The sensitivity was found to be significantly higher in CTSBT modality, comparing with each of the other diagnostic tests and even higher than in OGD and BSF together. Conclusions: CTSBT has been verified as the most efficient method to confirm or rule out SHH diagnosis or other anatomical abnormalities, which could be used to provide a surgeon with detailed information while making a decision about the advisability of LARS. Streszczenie Wprowadzenie: Rozpoznawanie wślizgowej przepukliny rozworu przełykowego (SHH) o rozmiarze mniejszym niż 3 cm z zastosowaniem fluoroskopii z barytem (BSF) i ezofagoduodendoskopii (OGD) zostało ostatnio uznane za mało wiarygodną metodę, pozwalającą na ok. 2 cm błędu w oszacowaniu jej wielkości. Cel pracy: Opracowanie metody, która może być wykorzystana do przedoperacyjnej wizualizacji i dokładnego anatomicznego obrazowania SHH i innych nieprawidłowości anatomicznych u pacjentów z chorobą refluksową przełyku (GORD). Materiał i metody: W latach 2015-2017 u 29 pacjentów (15 kobiet, średni wiek: 51 lat) z niepełną remisją GORD po odpowiedniej terapii lekowej, u których wcześniej zdiagnozowano GORD i podejrzewano SHH na podstawie wyników endoskopii i/lub BSF, wykonano tomografię komputerową z zastosowaniem sondy Sengstaken-Blakemore (CTSBT) przed laparoskopową operacją antyrefluksową (LARS) w celu potwierdzenia obecności przepukliny. Różnicę czułości testów diagnostycznych obliczono za pomocą testu McNemar's Chi-square. Wyniki: Przepuklinę rozpoznano u 21 pacjentów za pomocą OGD i/lub BSF, chociaż w trakcie operacji rozpoznanie potwierdzono tylko u 18 pacjentów. Czułość diagnostyczna była znacznie wyższa w zakresie modalności CTSBT, gdy porównano ją z każdym z pozostałych testów diagnostycznych, a nawet wyższa niż w OGD i BSF razem. New method of preoperative selection of patients with gastro-oesophageal reflux disease Med...
Introduction: Iatrogenic injuries to the trachea and main bronchi present one of the most dramatic complications traditionally treated by thoracotomy and transcervical-transtracheal approaches but almost never by video-assisted thoracic surgery.Aim: To evaluate our experience in a video-assisted thoracic surgery repair of iatrogenic tracheal lacerations. Material and methods: The group under analysis consisted of 5 consecutive patients (1 male, mean age: 52 years, range: 32-56 years) who were treated for postintubation and intraoperative damage to the tracheobronchial tree using video-assisted thoracic surgery within the period 2015-2018. Thoracic computed tomography and fibreoptic tracheobronchoscopy were used to confirm iatrogenic tracheal ruptures before surgery. The membranous rupture of the trachea was closed with interrupted absorbable sutures, which were additionally sutured through the oesophageal wall or the wall of the gastric conduit to strengthen the suture line. Postoperative treatment included broad-spectrum antibiotic therapy and control tracheobronchoscopy. Results: The average duration of thoracoscopic tracheal rupture repair with suture line reinforcement was 103 min (range: 60-180 min). All patients were treated thoracoscopically without resorting to open surgery and were discharged without any postoperative complications within 16 days (range: 8-22 days). Conclusions: The minimally invasive thoracoscopic approach may be the method of choice for the treatment of intraoperative and post-intubation injuries of the tracheobronchial tree.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.